Manuel Vega

This inventor holds 14 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Hanall Biopharma Co., Ltd., Hanall Pharmaceuticals, Co. Ltd, Catalyst Biosciences, Inc.. Active years: 2008-2013.

USPTO Granted Patents = 14 (Patent Applications = 7)

% Patents Active = 7.1

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 147(Granted Patents)

Location History:

Bahia Blanca, AR (2012)
Vigneux-sur-Seine, FR (2008 - 2013)

Company Filing History:

9 out of 27

Hanall Biopharma Co., Ltd.

patents

2 out of 2

Hanall Pharmaceuticals, Co. Ltd

patents

1 out of 26

Catalyst Biosciences, Inc.

patents

4. 1 out of 2

Hanall Pharmaceutical Company, Ltd.

Years Active: 2008-2013

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8383388 - Modified coagulation factor IX polypeptides and use thereof for treatment (2013-02-26),

2. 8252743 - Modified erythropoietin polypeptides and uses thereof for treatment (2012-08-28),

3. 8222209 - Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof (2012-07-17),

4. 8114839 - Protease resistant modified erythropoietin polypeptides (2012-02-14),

5. 8105573 - Protease resistant modified IFN beta polypeptides and their use in treating diseases (2012-01-31),

6. 8057787 - Protease resistant modified interferon-beta polypeptides (2011-11-15),

7. 8052964 - Interferon-β mutants with increased anti-proliferative activity (2011-11-08),

8. 7998930 - Modified growth hormones (2011-08-16),

9. 7998469 - Protease resistant interferon beta mutants (2011-08-16),

10. 7884073 - Modified growth hormone (2011-02-08),

11. 7650243 - Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules (2010-01-19),

12. 7647184 - High throughput directed evolution by rational mutagenesis (2010-01-12),

13. 7611700 - Protease resistant modified interferon alpha polypeptides (2009-11-03),

14. 7349812 - Method for determining the titer of biological agents in living target cells (2008-03-25),

Title: Manuel Vega: Pioneering Inventor from Vigneux-sur-Seine

Introduction: Manuel Vega is a distinguished inventor hailing from Vigneux-sur-Seine, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Manuel Vega holds several patents in the areas of renewable energy technologies, sustainable transportation solutions, and advanced materials science.

Career Highlights: With a career spanning over two decades, Manuel Vega has worked with leading research institutions and multinational companies to develop cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, Manuel Vega has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life. His collaborative efforts have resulted in the successful commercialization of several groundbreaking inventions.

Conclusion: Manuel Vega's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global technology landscape. His contributions continue to inspire the next generation of inventors and shape the future of technology.